Website: tempobioscience.com   |   LinkedIn: linkedin.com/company/tempo-bioscience-inc

Human Biology, In a Dish

How Tempo Bioscience builds patient-relevant iPSC cell models that make drug development more predictive

At a glance

  • Company: Tempo Bioscience (tempobioscience.com)
  • Founded: 2013, San Francisco, California
  • Focus: Human iPSC-derived cell models (2D, 3D spheroids, and organoids) and biosensor-based assays
  • Applications: Disease modeling, drug safety and toxicity testing, gene therapy dosing, biomarker development, and in vitro diagnostics
  • Working with PSG on: Sales and business development scaling

The problem with animal models and immortalized cells

Too many drugs that look safe and effective in rodents or cancer-derived cell lines fail in people. Those models simply don’t capture human biology, or the biology of a specific patient population.

Tempo Bioscience was founded to close that gap with human, patient-relevant cell models built from induced pluripotent stem cells (iPSCs).

Cleaner cells, by design

Tempo reprograms adult human cells into iPSCs, then differentiates them into the specific cell types researchers need. What sets Tempo apart is how: it is the sole manufacturer of human iPSC-derived cell types engineered using non-viral, nucleic-acid-free, serum-free, and feeder-free technologies. That means cleaner genetics, more consistent cells, and models that better reflect real human biology. Cells are available from healthy and diseased donors and can be manufactured at scale.

A growing library of human models

With more than 22 iPSC-derived cell types, Tempo supports models across the body:

  • Central and peripheral nervous system: cortical, motor, and sensory neurons, astrocytes, microglia, and Schwann cells
  • Blood-brain barrier: brain microvascular endothelial cells and pericytes to test how small molecules, biologics, gene therapies, and RNA therapies cross into the brain
  • Liver: hepatocytes, hepatic stellate cells, Kupffer cells, sinusoidal endothelial cells, and 3D liver models for toxicity and disease modeling
  • Heart, kidney, and skin: cardiomyocytes, kidney proximal tubule and podocyte 3D spheroids, keratinocytes, and melanocytes
  • Immune cells: CD14+ monocytes and phagocytes

Tempo pairs these cells with proprietary biosensor technology for live-cell readouts, so researchers can measure cellular responses in real time.